Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
ID Title Internal supervisors Phase
#OxKEN-2021/23 Immunometabolism in human adipose tissue – crosstalk between macrophages and adipocyte progenitors driving sex-specific adipose tissue expansion Jelena Bezbradica Mirkovic OxKEN
#OxKEN-2021/1 Machine learning to predict the development of psoriatic arthritis Daniel Prieto-Alhambra, Laura Coates, Sara Khalid OxKEN
#OxKEN-2021/2 Influence of Modifiable factors in PsA contributing to treat to target success (the IMPACT study) Laura Coates, Anushka Soni OxKEN
#OxKEN-2021/3 Elucidating T cell phenotype and function in frozen shoulder Stephanie Dakin, Christopher Buckley, Mark Coles OxKEN
#OxKEN-2021/4 Co-prevalence of liver disease in psoriatic disease (COLIPSO) Laura Coates, Hussein Al-Mossawi OxKEN
#OxKEN-2021/6 Delivering an ethnically diverse atlas of the inflamed and healthy human knee Sarah Snelling, Adam Cribbs, Christopher Buckley OxKEN
#OxKEN-2021/7 Molecular pathogenesis of Marfan Syndrome Tonia Vincent, Angus Wann OxKEN
#OxKEN-2021/8 Understanding and exploiting T cell antigen discrimination OxKEN
#OxKEN-2021/9 Dissecting the fibrotic landscape in Dupuytren’s disease Jagdeep Nanchahal, Christopher Buckley OxKEN
#OxKEN-2021/10 Human intradermal Staphylococcal challenge as a novel translational model to explore physiology, pathology and pharmacology James Fullerton, Duncan Richards OxKEN
#OxKEN-2021/11 Investigating functional consequences of disease-specific genomic enhancers in ankylosing spondylitis Matteo Vecellio OxKEN
#OxKEN-2021/12 Exploring HLA-B*27-targeted RNAi therapy for Ankylosing Spondylitis Liye Chen, Paul Bowness OxKEN
#OxKEN-2021/13 A single-cell genomics based investigation of spondyloarthritis Stephen Sansom, Paul Bowness OxKEN
#OxKEN-2021/14 Application of single cell omics to dissect tissue-immune cell crosstalk and identify targetable mediators of tissue fibrosis Dominic Furniss OxKEN
#OxKEN-2021/15 Understanding the role of lysosomal signalling in autoimmunity Anna Katharina (Katja) A Simon, Alex Clarke OxKEN
#OxKEN-2021/16 Gamma-delta intra-epithelial lymphocytes in coeliac disease OxKEN
#OxKEN-2021/17 Immune cell atlas of giant cell arteritis: the interplay between neutrophil and T cell Irina Udalova, Raashid Luqmani OxKEN
#OxKEN-2021/18 Investigating interactions between oxygen-sensing pathways and autoimmunity OxKEN
#OxKEN-2021/19 Iron control of immune responses OxKEN
#OxKEN-2021/20 Form meets function in synovium: Did the evolution of power and precision grip drive development of rheumatoid arthritis? Mark Coles, Christopher Buckley OxKEN
#OxKEN-2021/21 Mechanism to Therapy: Applying mechanism driven modelling to COVID-19 pathologies to accelerate therapeutic development for inflammatory disease. Mark Coles OxKEN
#OxKEN-2021/22 Identifying therapeutic combinations for immune mediated inflammatory disease using computational modelling, artificial intelligence and experimentation Mark Coles OxKEN
#OxKEN-2021/5 Tissue ecology in IBD: Diagnostic and therapeutic implications Fiona Powrie FRS, Matthias Friedrich OxKEN